Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Financial Results for the Three Months Ended January 31, 2025 (Under Japan GAAP)(Non-consolidated)
Heartseed, Nov-Jan (1Q) Ordinary Profit Loss Widens
Notice Regarding the Launch of the Analyst Report Issued by Shared Research Inc.
Notice Regarding the Completion of the enrollment in Phase 1/2 Clinical Trial (LAPiS Study)
Heartseed, Fiscal Year End Changed from October to December. Ordinary Profit is loss of 958 million yen
[Delayed]Financial Results for the Fiscal Year Ended October 31, 2024 (Under Japan GAAP)(Non-consolidated)
Notice Regarding the LAPiS Study Progress
Heartseed, The Current Fiscal Year's Ordinary Loss to Narrow
Notice Regarding the Revisions of Full-Year Financial Results Forecast for the Fiscal Year Ending October 31, 2024
Heartseed Inc., The Current Fiscal Year Ordinary Profit Loss to Narrow
[Delayed] Financial Results for the Nine Months Ended July 31, 2024 (Under Japan GAAP)(Non-consolidated)
Heartseed Inc., Third Quarter Cumulative (November-July) Ordinary Profit loss of 1.08 billion yen